The Centre for Community-Driven Research has become the latest patient-focused group to criticise the Pharmaceutical Benefits Advisory Committee's failure to recommend a simplified and faster reimbursement process for immunotherapies.
'Our job as advocates is to interpret what patients mean by hope, not to ignore it'
October 23, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
The health department's strategy is based on the 'hope' that sponsors do not submit and enforce their rights
October 24, 2024 - - Latest News -
Health department attempts to defer two-thirds of submissions to March meeting
October 24, 2024 - - Latest News -
Release of white paper from NZ's Valuing Life Medicines Access Summit
October 24, 2024 - - Latest News -
This has happened before, there was consultation, and it was managed without harming patients
October 23, 2024 - - Latest News -
Companies should reject the letters and proceed with their submissions
October 23, 2024 - - Latest News -
'Our job as advocates is to interpret what patients mean by hope, not to ignore it'
October 23, 2024 - - Latest News -
Daiichi Sankyo continues Australian growth trajectory
October 23, 2024 - - Latest News